Loading…

Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1

Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pediatrics 1990-06, Vol.149 (9), p.637-639
Main Authors: Bain, M D, Purkiss, P, Jones, M, Bingham, P, Stacey, T E, Chalmers, R A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763
cites cdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763
container_end_page 639
container_issue 9
container_start_page 637
container_title European journal of pediatrics
container_volume 149
creator Bain, M D
Purkiss, P
Jones, M
Bingham, P
Stacey, T E
Chalmers, R A
description Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment.
doi_str_mv 10.1007/BF02034752
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79891036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79891036</sourcerecordid><originalsourceid>FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotVYv3oWcPAirM8l20xy1fkLBi56XJDtLI_tRN1mk_96UFj0N7_C8w_AwdolwiwDq7uEZBMhczcURm2IuRYagimM2TUvICtT6lJ2F8AUJ1riYsImQSiIWU2YePUUzbHkcyMSWusip8a3vTKTAw-ic77aNcRT7jng99C2Pa-Lj4FPsa274xkS_q_34uOZxO_Qhlan1JoUNcTxnJ7VpAl0c5ox9Pj99LF-z1fvL2_J-lTnUKmZ5ZWEhlUKBlFOFyoGqXK3AWAQDEqwg60AjFMIKmc-1tSioKIQQ2qlCztj1_u5m6L9HCrFsfXDUNKajfgyl0otUljvwZg-69GsYqC43g2-TgxKh3Pks_30m-OpwdbQtVX_oQaD8BT4qb-U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79891036</pqid></control><display><type>article</type><title>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</title><source>Springer Nature - Connect here FIRST to enable access</source><creator>Bain, M D ; Purkiss, P ; Jones, M ; Bingham, P ; Stacey, T E ; Chalmers, R A</creator><creatorcontrib>Bain, M D ; Purkiss, P ; Jones, M ; Bingham, P ; Stacey, T E ; Chalmers, R A</creatorcontrib><description>Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/BF02034752</identifier><identifier>PMID: 2373116</identifier><language>eng</language><publisher>Germany</publisher><subject>Amino Acid Metabolism, Inborn Errors - diet therapy ; Female ; Heme - biosynthesis ; Heptanoates - urine ; Heptanoic Acids - urine ; Humans ; Infant ; Methionine - blood ; Phenylalanine - administration &amp; dosage ; Tyrosine - blood</subject><ispartof>European journal of pediatrics, 1990-06, Vol.149 (9), p.637-639</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</citedby><cites>FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2373116$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bain, M D</creatorcontrib><creatorcontrib>Purkiss, P</creatorcontrib><creatorcontrib>Jones, M</creatorcontrib><creatorcontrib>Bingham, P</creatorcontrib><creatorcontrib>Stacey, T E</creatorcontrib><creatorcontrib>Chalmers, R A</creatorcontrib><title>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment.</description><subject>Amino Acid Metabolism, Inborn Errors - diet therapy</subject><subject>Female</subject><subject>Heme - biosynthesis</subject><subject>Heptanoates - urine</subject><subject>Heptanoic Acids - urine</subject><subject>Humans</subject><subject>Infant</subject><subject>Methionine - blood</subject><subject>Phenylalanine - administration &amp; dosage</subject><subject>Tyrosine - blood</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEQhoMotVYv3oWcPAirM8l20xy1fkLBi56XJDtLI_tRN1mk_96UFj0N7_C8w_AwdolwiwDq7uEZBMhczcURm2IuRYagimM2TUvICtT6lJ2F8AUJ1riYsImQSiIWU2YePUUzbHkcyMSWusip8a3vTKTAw-ic77aNcRT7jng99C2Pa-Lj4FPsa274xkS_q_34uOZxO_Qhlan1JoUNcTxnJ7VpAl0c5ox9Pj99LF-z1fvL2_J-lTnUKmZ5ZWEhlUKBlFOFyoGqXK3AWAQDEqwg60AjFMIKmc-1tSioKIQQ2qlCztj1_u5m6L9HCrFsfXDUNKajfgyl0otUljvwZg-69GsYqC43g2-TgxKh3Pks_30m-OpwdbQtVX_oQaD8BT4qb-U</recordid><startdate>199006</startdate><enddate>199006</enddate><creator>Bain, M D</creator><creator>Purkiss, P</creator><creator>Jones, M</creator><creator>Bingham, P</creator><creator>Stacey, T E</creator><creator>Chalmers, R A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199006</creationdate><title>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</title><author>Bain, M D ; Purkiss, P ; Jones, M ; Bingham, P ; Stacey, T E ; Chalmers, R A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Amino Acid Metabolism, Inborn Errors - diet therapy</topic><topic>Female</topic><topic>Heme - biosynthesis</topic><topic>Heptanoates - urine</topic><topic>Heptanoic Acids - urine</topic><topic>Humans</topic><topic>Infant</topic><topic>Methionine - blood</topic><topic>Phenylalanine - administration &amp; dosage</topic><topic>Tyrosine - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bain, M D</creatorcontrib><creatorcontrib>Purkiss, P</creatorcontrib><creatorcontrib>Jones, M</creatorcontrib><creatorcontrib>Bingham, P</creatorcontrib><creatorcontrib>Stacey, T E</creatorcontrib><creatorcontrib>Chalmers, R A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bain, M D</au><au>Purkiss, P</au><au>Jones, M</au><au>Bingham, P</au><au>Stacey, T E</au><au>Chalmers, R A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1990-06</date><risdate>1990</risdate><volume>149</volume><issue>9</issue><spage>637</spage><epage>639</epage><pages>637-639</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><abstract>Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment.</abstract><cop>Germany</cop><pmid>2373116</pmid><doi>10.1007/BF02034752</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6199
ispartof European journal of pediatrics, 1990-06, Vol.149 (9), p.637-639
issn 0340-6199
1432-1076
language eng
recordid cdi_proquest_miscellaneous_79891036
source Springer Nature - Connect here FIRST to enable access
subjects Amino Acid Metabolism, Inborn Errors - diet therapy
Female
Heme - biosynthesis
Heptanoates - urine
Heptanoic Acids - urine
Humans
Infant
Methionine - blood
Phenylalanine - administration & dosage
Tyrosine - blood
title Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T16%3A38%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dietary%20treatment%20eliminates%20succinylacetone%20from%20the%20urine%20of%20a%20patient%20with%20tyrosinaemia%20type%201&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=Bain,%20M%20D&rft.date=1990-06&rft.volume=149&rft.issue=9&rft.spage=637&rft.epage=639&rft.pages=637-639&rft.issn=0340-6199&rft.eissn=1432-1076&rft_id=info:doi/10.1007/BF02034752&rft_dat=%3Cproquest_cross%3E79891036%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79891036&rft_id=info:pmid/2373116&rfr_iscdi=true